Literature DB >> 27564118

Reply.

Jennifer M Hootman1, Charles G Helmick1.   

Abstract

Entities:  

Year:  2016        PMID： 27564118      PMCID： PMC6078392          DOI： 10.1002/art.39838

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  7 in total

1.  Problems in the development and validation of questionnaire-based screening instruments for ascertaining cases with symptomatic knee osteoarthritis: the Framingham Study.

Authors:  M LaValley; T E McAlindon; S Evans; C E Chaisson; D T Felson
Journal:  Arthritis Rheum       Date:  2001-05

2.  Validation of a surveillance case definition for arthritis.

Authors:  Jeffrey J Sacks; Leslie R Harrold; Charles G Helmick; Jerry H Gurwitz; Srinivas Emani; Robert A Yood
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

3.  Projections of US prevalence of arthritis and associated activity limitations.

Authors:  Jennifer M Hootman; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2006-01

4.  Validity of self-reported rheumatoid arthritis in elderly women.

Authors:  V L Star; J C Scott; R Sherwin; N Lane; M C Nevitt; M C Hochberg
Journal:  J Rheumatol       Date:  1996-11       Impact factor: 4.666

5.  Characteristics of subjects self-reporting arthritis in a population health survey: distinguishing between types of arthritis.

Authors:  Genevieve Gariepy; Michel Rossignol; Abby Lippman
Journal:  Can J Public Health       Date:  2009 Nov-Dec

6.  Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health Study.

Authors:  Margaret K Formica; Timothy E McAlindon; Timothy L Lash; Serkalem Demissie; Lynn Rosenberg
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

7.  Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2010-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-11-08       Impact factor: 17.586
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.